Clinical Updates on Immune-directed Therapies in MS: Expert Insights & Real World Evidence

Access Activity

Overview / Abstract:

Target Audience

This activity is designed to meet the educational needs of Neurologists and MS nurse specialists, as well as other clinicians treating and managing patients with MS.

Program Overview

Recent advances in the field of immunology and the increasing recognition of inflammatory pathways are re-shaping the conceptualization of multiple sclerosis (MS), with potential implications of new agents within the current landscape of treatment options. This CME/CNE activity features clinicians and researchers who will provide expert insights and updated evidence for immune-directed strategies in MS. Their presentations will describe the rationale for immune system reset along with supporting clinical evidence, and identify risks and benefits of current and emerging DMTs, including understanding of complications (i.e., infections, malignancy potential), as well as strategies for optimizing sequencing of therapies in individualized MS patient care.

Learning Objectives

After participating in this accredited satellite symposium, the learner should be able to:

Describe critical advances and emerging immune-directed therapies that will change the therapeutic approach to MS.
Review the immunologic rationale, safety, and clinical efficacy of supporting an immune system reset.
Identify clinical considerations when evaluating risks and benefits in deciding on DMT therapy.
Summarize the concept of immunosenescence and the importance of vigilance in monitoring the risk of infections especially in older MS patients.
Using real-world patient case challenges, discuss strategies to therapeutic optimization and patient selection, as well as ongoing safety monitoring and AE management of patients with RMS.

Expiration

Apr 20, 2021

Discipline(s)

Nursing CNE, Physician CME

Format

Online

Credits / Hours

1.0 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty

Mark Freedman, MSc, MD, FANA, FAAN, FRCPC, Co-Chair
Senior Scientist, Neuroscience Program
Ottawa Hospital Research Institute
Professor of Medicine, Neurology
University of Ottawa
Director, MS Research Unit, Neurology
Ottawa Hospital-General Campus
Ottawa, Canada

Patricia K. Coyle, MD, FAAN, FANA, Co-Chair
Professor and Interim Chair, Dept. of Neurology
Director, MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York

Sponsors / Supporters / Grant Providers

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany.

Keywords / Search Terms

Relias LLC Relias LLC., FREE CME, Immune-directed Therapies Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map